Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...
Las Vegas will dazzle with a first-of-its-kind drone show synchronized with spectacular fireworks from 10 of the city's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果